Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Molecules ; 28(9)2023 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-37175371

RESUMEN

Isatidis folium or Isatis tinctoria L. is a flowering plant of the Brassicaceae family, commonly known as woad, with an ancient and well-documented history as an indigo dye and medicinal plant. This study aimed to evaluate the anti-atopic dermatitis (AD) effects of Isatidis folium water extract (WIF) using a 2,4-dinitrochlorobenzene (DNCB)-induced AD-like mouse model and to investigate the underlying mechanism using tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ)-activated HaCaT cells. Oral administration of WIF reduced spleen weight, decreased serum IgE and TNF-α levels, reduced epidermal and dermal thickness, and inhibited eosinophil and mast cell recruitment to the dermis compared to DNCB-induced control groups. Furthermore, oral WIF administration suppressed extracellular signal-regulated kinase and p38 mitogen-activated protein kinase protein expression levels, p65 translocation from the cytoplasm to the nucleus, and mRNA expression of TNF-α, IFN-γ, interleukin (IL)-6, and IL-13 in skin lesion tissues. In HaCaT cells, WIF suppressed the production of regulated upon activation, normal T cell expressed and secreted (RANTES), thymus and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC), MCP-1, and MIP-3a, which are inflammatory cytokines and chemokines related to AD, and inhibited the mRNA expression of RANTES, TARC, and MDC in TNF-α/IFN-γ-stimulated HaCaT cells. Overall, the results revealed that WIF ameliorated AD-like skin inflammation by suppressing proinflammatory cytokine and chemokine production via nuclear factor-κB pathway inhibition, suggesting WIF as a potential candidate for AD treatment.


Asunto(s)
Dermatitis Atópica , Factor de Necrosis Tumoral alfa , Animales , Ratones , Humanos , Factor de Necrosis Tumoral alfa/metabolismo , Dinitroclorobenceno/efectos adversos , Dinitroclorobenceno/metabolismo , Queratinocitos , Interferón gamma/metabolismo , Agua/metabolismo , Células HaCaT , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/metabolismo , Citocinas/metabolismo , FN-kappa B/metabolismo , Quimiocinas/metabolismo , ARN Mensajero/genética
2.
J Cosmet Dermatol ; 22(5): 1602-1612, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-36639978

RESUMEN

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a genetic predisposition, and the traditional Chinese medicine Morinda officinalis and its roots are characterized with anti-inflammatory effects and have been used for the treatment of various disease. However, it is still largely unknown whether Morinda officinalis extract (MOE) can be used for the treatment of AD. OBJECTIVES: In our study we aimed to determine whether MOE could ameliorate 2,4-dinitrochlorobenzene (DNCB)-induced AD and elucidate molecular mechanisms. METHODS: We established an AD mouse model by using DNCB. Skin pathological analysis and ELISA assay were used to detect the effect of MOE on the inflammation of AD model mouse skin and the expression changes of inflammatory factors, and further functional verification was performed in TNF-α/IFN-γ-induced HaCaT cells. RESULTS: Our in vivo experiments confirmed that MOE remarkably reduced DNCB-induced AD lesions and symptoms, such as epidermal and dermal thickness and mast cell infiltration and inflammatory cytokines secretion in the mice models. In addition, the underlying mechanisms by which MOE ameliorated AD had been uncovered, and we verified that MOE inhibited MALAT1 expression in AD, resulting in attenuated expression of C-C chemokine receptor type 7 (CCR7) regulated by MALAT1-sponge miR-590-5p in a competing endogenous RNA (ceRNA) mechanisms-dependent manner, thereby inhibiting TNF-α/IFN-γ-induced cellular proliferation and inflammation.


Asunto(s)
Dermatitis Atópica , MicroARNs , Morinda , ARN Largo no Codificante , Animales , Ratones , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/genética , Morinda/metabolismo , ARN Largo no Codificante/genética , Factor de Necrosis Tumoral alfa/metabolismo , Dinitroclorobenceno/metabolismo , Dinitroclorobenceno/farmacología , Dinitroclorobenceno/uso terapéutico , Receptores CCR7/metabolismo , Receptores CCR7/uso terapéutico , Antiinflamatorios/uso terapéutico , Piel/metabolismo , Inflamación/patología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Extractos Vegetales/metabolismo , Citocinas/metabolismo
3.
Mar Drugs ; 20(11)2022 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-36354992

RESUMEN

Laminarin is a polysaccharide isolated from brown marine algae and has a wide range of bioactivities, including immunoregulatory and anti-inflammatory properties. However, the effects of laminarin on atopic dermatitis have not been demonstrated. This study investigated the potential effects of topical administration of laminarin using a Balb/c mouse model of oxazolone-induced atopic dermatitis-like skin lesions. Our results showed that topical administration of laminarin to the ear of the mice improved the severity of the dermatitis, including swelling. Histological analysis revealed that topical laminarin significantly decreased the thickening of the epidermis and dermis and the infiltration of mast cells in the skin lesion. Serum immunoglobulin E levels were also significantly decreased by topical laminarin. Additionally, topical laminarin significantly suppressed protein levels of oxazolone-induced proinflammatory cytokines, such as interleukin-1ß, tumor necrosis factor-α, monocyte chemoattractant protein-1, and macrophage inflammatory protein-1α in the skin lesion. These results indicate that topical administration of laminarin can alleviate oxazolone-induced atopic dermatitis by inhibiting hyperproduction of IgE, mast cell infiltration, and expressions of proinflammatory cytokines. Based on these findings, we propose that laminarin can be a useful candidate for the treatment of atopic dermatitis.


Asunto(s)
Dermatitis Atópica , Ratones , Animales , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/metabolismo , Oxazolona/toxicidad , Oxazolona/metabolismo , Dinitroclorobenceno/metabolismo , Dinitroclorobenceno/farmacología , Dinitroclorobenceno/uso terapéutico , Inmunoglobulina E , Extractos Vegetales/farmacología , Administración Tópica , Citocinas/metabolismo , Ratones Endogámicos BALB C , Piel
4.
Clin Immunol ; 244: 109102, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-36049600

RESUMEN

Atopic dermatitis (AD), a type of skin inflammation, is associated with immune response mediated by T-helper 2 (Th2) cells, and mast cells. Vasicine is an alkaloid isolated from Adhatoda vasica, a popular Ayurvedic herbal medicine used for treating inflammatory conditions. In the present study, the anti-AD effects of vasicine were evaluated on 2,4-dinitrochlorobenzene-induced AD-like skin lesions in BALB/c mice. The potential anti-allergic effects of vasicine were also assessed using the passive cutaneous anaphylaxis (PCA) test. The results showed that the oral administration of vasicine improved the severity of AD-like lesional skin by decreasing histopathological changes and restoring epidermal thickness. Vasicine also inhibited the infiltration of mast cells in the skin and reduced the levels of pro-Th2 and Th2 cytokines as well as immunoglobulin E in the serum. Finally, vasicine inhibited the expression of pro-Th2 and Th2 cytokines in skin tissues, indicating the therapeutic potential of vasicine for AD.


Asunto(s)
Alcaloides , Antialérgicos , Dermatitis Atópica , Enfermedades de la Piel , Alcaloides/metabolismo , Alcaloides/farmacología , Alcaloides/uso terapéutico , Animales , Antialérgicos/efectos adversos , Citocinas , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dinitroclorobenceno/metabolismo , Dinitroclorobenceno/farmacología , Dinitroclorobenceno/uso terapéutico , Inmunoglobulina E , Ratones , Ratones Endogámicos BALB C , Anafilaxis Cutánea Pasiva , Quinazolinas , Piel , Enfermedades de la Piel/patología
5.
Biosci Biotechnol Biochem ; 86(5): 646-654, 2022 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-35218182

RESUMEN

Atopic dermatitis (AD) is a chronic inflammatory and pruritic disease; it can be treated by inhibiting inflammation. Sarcodia suiae sp. is an edible, artificially cultivable red algae with multiple bioactivities. We assessed the anti-inflammatory activity of the ethyl acetate fraction of S. suiae sp. ethanol extract (PD1) on 1-chloro-2,4-dinitrochlorobenzene (DNCB)-induced AD-like lesions. Results show that PD1 alleviated symptoms and significantly decreased clinical dermatitis score. PD1 inhibited serum immunoglobulin E expression and alleviated swelling in the spleen and subiliac lymph nodes. In skin tissues, PD1 alleviated aberrant hyperplasia, decreased epidermal thickness, and decreased the accumulation of mast cells. PD1 mediated the recovery of skin barrier-related proteins, such as claudin-1 and filaggrin. Our study demonstrated that PD1 has anti-inflammatory effects, alleviates AD symptoms, inhibits inflammatory responses in skin tissues, and restores barrier function in DNCB-induced AD mice. These findings reveal that S. suiae sp. extract provides an alternative protective option against AD.


Asunto(s)
Dermatitis Atópica , Rhodophyta , Acetatos , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Citocinas/metabolismo , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/metabolismo , Dinitroclorobenceno/metabolismo , Dinitroclorobenceno/farmacología , Dinitroclorobenceno/uso terapéutico , Etanol/metabolismo , Inflamación/metabolismo , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/metabolismo , Rhodophyta/metabolismo , Piel
6.
Molecules ; 28(1)2022 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-36615486

RESUMEN

Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Bisdemethoxycurcumin (BDMC) is an ingredient from the rhizome of the traditional Chinese herbal medicine turmeric. BDMC has been reported to have important pharmacological properties, such as anti-inflammatory, antioxidant, antitumor and antiproliferative activities. However, its effect on atopic dermatitis has not been reported. The purpose of our study was to demonstrate the effectiveness of BDMC on TNF-α/IFNγ-stimulated HaCaT cells and on 2,4-dinitrochlorobenzene (DNCB)-induced AD mice. Our studies showed in vitro that BDMC was able to significantly inhibit the mRNA expression of chemokines and cytokines in TNF-α/IFN-γ-stimulated HaCaT cells and alleviate their inflammatory response. Our studies found in vivo that BDMC was able to significantly improve the symptoms of DNCB-induced AD skin lesions, decrease the number of scratches, ear thickness, and spleen index, improve inflammatory cells and mast cell infiltration and decrease skin thickness. Moreover, it was also able to inhibit the mRNA expression levels of chemokines and inflammatory cytokines and the activation of the MAPK and NF-κB signaling pathways. Thus, the results indicated that BDMC can improve atopic dermatitis in mice and that further clinical studies are warranted on its treatment of AD.


Asunto(s)
Dermatitis Atópica , Animales , Ratones , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/patología , Dinitroclorobenceno/metabolismo , Queratinocitos , Factor de Necrosis Tumoral alfa/metabolismo , Piel , Citocinas/metabolismo , Quimiocinas/genética , Quimiocinas/metabolismo , FN-kappa B/metabolismo , ARN Mensajero/metabolismo , Ratones Endogámicos BALB C
7.
Molecules ; 26(17)2021 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-34500860

RESUMEN

Artemisia anomala S. Moore is a perennial herbaceous plant classified as Asteraceae of the genus Artemisia. Many species of Artemisia have been used as medicinal materials. Artemisia anomala S. Moore has been widely used in China to treat inflammatory diseases. However, the mechanism of its action on the keratinocyte inflammatory response is poorly understood. Here, we investigated the anti-inflammatory reaction of Artemisia anomala S. Moore ethanol extract (EAA) using human keratinocyte (HaCaT) cells, which involved investigating the nuclear factor kappa B (NF-κB), signal transducer, and activator of transcription-1 (STAT-1), as well as mitogen-activated protein kinase (MAPK) signaling pathways and atopic dermatitis-like skin lesions in mice. We elucidated the anti-inflammatory effects of EAA on tumor necrosis factor-α/interferon-γ (TNF-α/IFN-γ)-treated human keratinocyte cells and 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like mice. The levels of chemokines and cytokines (IL-8, IL-6, TARC, and RANTES) were determined by an enzyme-linked immunosorbent assay. The NF-κB, STAT-1, and MAPK signaling pathways in HaCaT cells were analyzed by western blotting. Thickening of the mice dorsal and ear skin was measured and inflammatory cell infiltration was observed by hematoxylin and eosin staining. Results showed that EAA suppressed IL-8, IL-6, TARC, and RANTES production. EAA inhibited nuclear translocation of NFκB and STAT-1, as well as reduced the levels of phosphorylated ERK MAPKs. EAA improved AD-like skin lesions in DNCB-treated mice. These findings suggest that EAA possesses stronger anti-inflammatory properties and can be useful as a functional food or candidate agent for AD.


Asunto(s)
Antiinflamatorios/química , Artemisia/química , Dermatitis Atópica/metabolismo , Dinitroclorobenceno/química , Mediadores de Inflamación/química , Extractos Vegetales/química , Animales , Antiinflamatorios/farmacología , Quimiocinas/metabolismo , Citocinas/metabolismo , Dinitroclorobenceno/metabolismo , Modelos Animales de Enfermedad , Células HaCaT , Humanos , Mediadores de Inflamación/farmacología , Interferón gamma/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Extractos Vegetales/metabolismo , Factor de Transcripción STAT1 , Transducción de Señal , Piel , Factor de Necrosis Tumoral alfa/metabolismo
8.
Toxicol In Vitro ; 26(4): 630-5, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22401947

RESUMEN

Nonsynonymous single nucleotide polymorphisms in glutathione s-transferase pi 1 (GSTP1; Ile/Val 105, Ala/Val 114) have been associated with altered toxicant metabolism in epidemiological cohorts. We explored the impact of GSTP1 genotype on enzyme kinetics and heavy metal inhibition in vitro. Four GSTP1 allozymes (105/114: Ile/Ala, Val/Ala, Ile/Val, Val/Val) were expressed in and purified from Escherichia coli. Enzyme activity assays quantifying the rate of glutathione conjugation with 1-chloro-2,4-dinitrobenzene (CDNB) revealed significant differences in kinetic parameters depending on genotype (p<0.01). Allozymes with Ile105 had better catalytic efficiency and greater affinity for CDNB (mean ± SEM: Ile105 Ala114 K(m)=0.33 ± 0.07 mM vs. Val105 Ala114 K(m)=1.15 ± 0.07 mM). Inhibition of GSTP1 activity by heavy metals was assessed following treatment with mercury (inorganic-HgCl(2), methylmercury-MeHg), selenium, cadmium, lead, arsenic, and manganese. All allozymes were inhibited by HgCl(2) (IC(50) range: 24.1-172 µM), MeHg (93.9-480 µM), and selenium (43.7-62.8 µM). Genotype significantly influenced the potency of mercury with GSTP1 Ile105 Val114 the least sensitive and Val105 Ala114 the most sensitive to inhibition by HgCl(2) and MeHg. Overall, genotype of two nonsynonymous polymorphisms in GSTP1 influenced enzyme kinetics pertaining to an electrophilic substrate and inhibition by two mercury species.


Asunto(s)
Arsénico/toxicidad , Gutatión-S-Transferasa pi/metabolismo , Metales Pesados/toxicidad , Compuestos de Metilmercurio/toxicidad , Selenio/toxicidad , Dinitroclorobenceno/metabolismo , Escherichia coli/genética , Genotipo , Glutatión/metabolismo , Gutatión-S-Transferasa pi/genética , Isoenzimas , Mutación
9.
BMC Complement Altern Med ; 10: 51, 2010 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-20846448

RESUMEN

BACKGROUND: Several cell culture and animal studies demonstrated that citrus bioactive compounds have protective effects against certain types of cancer. Among several classes of citrus bioactive compounds, limonoids were reported to prevent different types of cancer. Furthermore, the structures of citrus limonoids were reported to influence the activity of phase II detoxifying enzymes. The purpose of the study was to evaluate how variations in the structures of citrus limonoids (namely nomilin, deacetyl nomilin, and isoobacunoic acid) and a mixture of limonoids would influence phase II enzyme activity in excised tissues from a mouse model. METHODS: In the current study, defatted sour orange seed powder was extracted with ethyl acetate and subjected to silica gel chromatography. The HPLC, NMR and mass spectra were used to elucidate the purity and structure of compounds. Female A/J mice were treated with three limonoids and a mixture in order to evaluate their effect on phase II enzymes in four different tissues. Assays for glutathione S-transferase and NAD(P)H: quinone reductase (QR) were used to evaluate induction of phase II enzymatic activity. RESULTS: The highest induction of GST against 1-chloro-2,4-dinitrobenzene (CDNB) was observed in stomach (whole), 58% by nomilin, followed by 25% isoobacunoic acid and 19% deacetyl nomilin. Deacetyl nomilin in intestine (small) as well as liver significantly reduced GST activity against CDNB. Additionally isoobacunoic acid and the limonoid mixture in liver demonstrated a significant reduction of GST activity against CDNB. Nomilin significantly induced GST activity against 4-nitroquinoline 1-oxide (4NQO), intestine (280%) and stomach (75%) while deacetyl nomilin showed significant induction only in intestine (73%). Induction of GST activity was also observed in intestine (93%) and stomach (45%) treated with the limonoid mixture. Finally, a significant induction of NAD(P)H: quinone reductase (QR) activity was observed by the limonoid mixture in stomach (200%). In addition, the deacetyl nomilin treatment group displayed an increase in QR activity in liver (183%) and intestine (22%). CONCLUSION: The results of the present study suggests that, dietary intake of citrus limonoids may provide a protective effect against the onset of various cancers by inducing the activity of certain phase II detoxifying enzymes in specific organs.


Asunto(s)
Citrus/química , Dinitroclorobenceno/metabolismo , Glutatión Transferasa/metabolismo , Limoninas/farmacología , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Preparaciones de Plantas/farmacología , Triterpenos/farmacología , Animales , Benzoxepinas/farmacología , Femenino , Intestino Delgado/enzimología , Hígado/enzimología , Fase II de la Desintoxicación Metabólica , Ratones , Ratones Endogámicos , Modelos Animales , Preparaciones de Plantas/química , Polvos , Semillas , Estómago/enzimología , Triterpenos/aislamiento & purificación
11.
J Enzyme Inhib Med Chem ; 25(6): 854-62, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20521884

RESUMEN

A glutathione transferase (PfGST) isolated from Plasmodium falciparum has been associated with chloroquine resistance. A range of natural products including malagashanine (MG) were screened for inhibition of PfGST by a GST assay with 1-chloro-2,4-dinitrobenzene as a substrate. Only the sesquiterpene (JBC 42C), the bicoumarin (Tral-1), ellagic acid and curcumin, were shown to be potent inhibitors of PfGST with IC(50) values of 8.5, 12, 50 and 69 µM, respectively. Kinetic studies were performed on PfGST using ellagic acid as an inhibitor. Uncompetitive and mixed types of inhibition were obtained for glutathione (GSH) and 1-chloro-2, 4-dinitrobenzene (CDNB). The K(i) for GSH and CDNB were -0.015 µM and 0.011 µM, respectively. Malagashanine (100 µM) only reduced the activity of PfGST to 80% but showed a time-dependent inactivation of PfGST with a t(1/2) of 34 minutes compared to >120 minutes in the absence of MG or in the presence of 5 mM GSH. This work facilitates the understanding of the interaction of PfGST with some plant derived compounds.


Asunto(s)
Alcaloides/farmacología , Productos Biológicos/farmacología , Descubrimiento de Drogas , Inhibidores Enzimáticos/farmacología , Glutatión Transferasa/antagonistas & inhibidores , Plantas Medicinales/química , Plasmodium falciparum/enzimología , Proteínas Protozoarias/antagonistas & inhibidores , Cloroquina/farmacología , Cumarinas/farmacología , Curcumina/farmacología , Dinitroclorobenceno/metabolismo , Resistencia a Medicamentos , Ácido Elágico/farmacología , Glutatión/metabolismo , Glutatión Transferasa/genética , Glutatión Transferasa/aislamiento & purificación , Glutatión Transferasa/metabolismo , Cinética , Malaria Falciparum/tratamiento farmacológico , Proteínas Protozoarias/genética , Proteínas Protozoarias/aislamiento & purificación , Proteínas Protozoarias/metabolismo , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/química , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Sesquiterpenos de Germacrano/farmacología
12.
Pharmazie ; 65(5): 367-74, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20503931

RESUMEN

Traditional Chinese herbal medicines are frequently prescribed in pharmacotherapy in Japan. In the present study, we evaluated the possible interaction of several herbal extracts including Rhei Rhizoma extract with cytochrome P450 (CYP) 3A and efflux transporters such as P-glycoprotein and multidrug resistance-associated protein (MRP) 2. Rhei Rhizoma extract (100 microg/ml) significantly suppressed the CYP3A-mediated 6beta-hydroxylation of testosterone in hepatic microsomes, and increased the extent of bioavailability of midazolam, a typical CYP3A substrate, in rats. Also, Rhei Rhizoma extract (300 microg/ml) significantly suppressed P-glycoprotein-mediated efflux transport of rhodamine 123 (Rho123) in rat everted intestine. In an in-vivo study, Rhei Rhizoma extract added to intestinal perfusate at a concentration of 300 microg/ml significantly suppressed the intestinal exsorption of Rho123, though it exerted no effect on the biliary excretion of Rho123. Furthermore, the in-vitro and in-vivo MRP2-mediated intestinal efflux of 2,4-dinitrophenyl-S-glutathione was significantly suppressed by Rhei Rhizoma extract (1000 microg/ml). In conclusion, Rhei Rhizoma extract, which is taken orally at doses of 0.5-1 g each or 1-3 g daily in clinical practice, may cause pharmacokinetic herb-drug interactions in the process of the intestinal and/or hepatic CYP3A-mediated drug metabolism and P-glycoprotein- and/or MRP2-mediated efflux transport in the intestine.


Asunto(s)
Proteínas Portadoras/metabolismo , Citocromo P-450 CYP3A/metabolismo , Rheum/química , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Transportadoras de Casetes de Unión a ATP/metabolismo , Animales , Ciclosporina/farmacología , Dinitroclorobenceno/metabolismo , Moduladores del GABA/farmacocinética , Glutatión/análogos & derivados , Glutatión/metabolismo , Inmunosupresores/farmacología , Indicadores y Reactivos , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Midazolam/farmacocinética , Extractos Vegetales/farmacología , Ratas , Ratas Sprague-Dawley , Rodamina 123
13.
Aquat Toxicol ; 83(2): 104-15, 2007 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-17459495

RESUMEN

We cloned and sequenced the full-length cDNA of a theta class glutathione S-transferase (GST-T) from the polychaete Neanthes succinea. The open reading frame of N. succinea GST-T cDNA was 678bp and encoded 226 amino acid residues. We generated recombinant N. succinea GST-T by expression in transformed Escherichia coli and studied the kinetic properties as well as the effects of inhibitors, pH, and temperature on N. succinea GST-T. GST-T expression was studied using real-time RT-PCR in response to exposure to the model oxidative stress-inducing agent, CuCl(2). Copper induced a concentration-dependant increase in the expression of GST-T. Moreover, polychaetes collected from a heavily contaminated lake near an industrial complex showed significantly higher levels of GST-T expression. Interestingly, the site-collected polychaetes with the highest GST-T mRNA expression levels also showed the highest metallothioneins levels. These results suggest that GST-T in polychaetes may have an antioxidant role and that N. succinea GST-T expression may be a useful biomarker for exposure to environmental contaminants such as copper. Our findings provide a better understanding of the biochemical characteristics of N. succinea GST-T, and elucidate the potential role of GST-T in heavy metal-induced oxidative stress and as a biomarker for environmental contamination.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Glutatión Transferasa/biosíntesis , Glutatión Transferasa/genética , Poliquetos/enzimología , Poliquetos/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Biomarcadores/análisis , Clonación Molecular , Cobre/toxicidad , ADN Complementario/química , Dinitroclorobenceno/metabolismo , Etilmaleimida/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Sedimentos Geológicos/análisis , Glutatión/metabolismo , Glutatión Transferasa/análisis , Glutatión Transferasa/metabolismo , Hemina/farmacología , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Filogenia , Poliquetos/clasificación , Proteínas Recombinantes/análisis , Proteínas Recombinantes/biosíntesis , Temperatura , Triazinas/farmacología , Contaminantes Químicos del Agua/toxicidad
14.
Gene ; 206(1): 99-105, 1998 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-9461421

RESUMEN

A cDNA library was constructed from mRNA of the rhesus monkey kidney cell line, FRHK, and the cDNA sequence for an FRHK glutathione S-transferase (GST) Pi was determined using a RACE method. This represents the first full-length monkey GST Pi sequence to be cloned and determined. The similarity to the human GST Pi was found to be extensive (more than 97%), the deduced protein differing only in six amino acids (aa) positions. FRHK GST Pi was expressed in bacteria and a recombinant protein was purified which demonstrated significant activity towards the substrates 1-chloro-2,4-dinitrobenzene (CDNB) and 1,2-epoxy-3-para-nitrophenoxypropane. Western blots also showed significant amounts of protein, both in the FRHK cells and transformed bacteria. The FRHK GST Pi was found to contain a phenylalanine at aa position 68, a position which is otherwise invariably occupied by an isoleucine in the GST Pi, Alpha, Mu and Beta class enzymes investigated. An isoleucine in this position is thus not essential for activity in the FRHK enzyme, unlike the human GST pi, where the exchange of Ile68 to a tyrosine (Manoharan, T.H, Gulick, A.M., Puchalski, R.B., Servais, A.L., Fahl, W.E., 1992. J. Biol. Chem., 267, 18940-18945), resulted in total loss of activity. Phe68 was mutated to Ile in the FRHK GST Pi enzyme to determine whether the wild type amino acid conferred an impaired catalytic site. The resulting mutant did not show any changes in activity towards CDNB, clearly demonstrating that isoleucine at position 68 is not essential. Thus, the first monkey GST Pi enzyme has been characterized, an enzyme with many similarities to the human forms although it differs in an otherwise conserved residue at aa position 68. This difference does not appear to affect the function of the FRHK GST Pi.


Asunto(s)
Dinitroclorobenceno/metabolismo , Glutatión Transferasa/genética , Isoenzimas/genética , ARN Mensajero , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Western Blotting , Línea Celular , ADN Complementario , Electroforesis en Gel de Poliacrilamida , Gutatión-S-Transferasa pi , Glutatión Transferasa/metabolismo , Humanos , Isoenzimas/metabolismo , Isoleucina/genética , Isoleucina/metabolismo , Riñón/citología , Macaca mulatta , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Fenilalanina/genética , Fenilalanina/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Dodecil Sulfato de Sodio , Especificidad por Sustrato
15.
Eur J Drug Metab Pharmacokinet ; 23(4): 497-500, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10323333

RESUMEN

An investigation was made of ethoxyresorufin O-deethylase (EROD) activity, a cytochrome P450 (CYP) dependent enzyme mainly catalyzed by CYP1A1, glutathione S-transferase (GST) activity toward the substrates 1-chloro-2,4- dinitrobenzene (CDNB) and ethacrynic acid (EAA), reduced glutathione (GSH) levels, and antioxidant enzyme (AOE) activity namely catalase (CAT) and selenium- dependent glutathione peroxidase (Se-GPx) in tumor and surrounding tumor-free (normal) tissues in female breast cancer patients. Wide interindividual variations were found in the enzyme activities in both tumor and normal breast tissues. No significant differences were noted between mean EROD and CAT activities in tumor and normal breast tissues. The mean activities of CDNB GST, EAA GST and Se-GPx and GSH levels in tumor tissue were significantly higher than those in normal breast tissue. These results show that CYP, GST and AOE behave differentially in breast tumors.


Asunto(s)
Neoplasias de la Mama/enzimología , Mama/enzimología , Enzimas/metabolismo , Antioxidantes/metabolismo , Catalasa/metabolismo , Citocromo P-450 CYP1A1/metabolismo , Dinitroclorobenceno/metabolismo , Ácido Etacrínico/metabolismo , Femenino , Glutatión Peroxidasa/metabolismo , Glutatión Transferasa/metabolismo , Humanos , Selenio/fisiología , Xenobióticos/metabolismo
16.
Comp Biochem Physiol B Biochem Mol Biol ; 117(1): 109-14, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9180019

RESUMEN

Phospholipid hydroperoxide glutathione peroxidase (PHGPX) is the second identified Se-dependent intracellular glutathione peroxidase (PHGPX) that reduces phospholipid hydroperoxides. The objective of this study was to determine the developmental regulation of PHGPX expression in tissues of neonatal, weanling and finishing pigs (Sus scrofa) compared with the expression of the classic Se-dependent cellular glutathione peroxidase (GPX) and the Se-independent enzyme, glutathione S-transferase (GST). Eight different tissues were collected from Se-adequate male pigs aged 1, 28 and 180 days, and supernatant of the tissue homogenate was assayed for PHGPX, GPX and GST activities by using phosphatidylcholine hydroperoxide, hydrogen peroxide and 1-chloro-2,4-dinitrobenzene as substrate, respectively. Total RNA was isolated from four tissues and assayed for PHGPX mRNA expression. Both mRNA and activity expression of PHGPX in most assayed tissues was increased as pigs became older (P < 0.05), but increases in PHGPX mRNA levels between ages did not fully account for all changes in activity. Expression of GPX activity was increased more than that of PHGPX between day 1 and day 28 (P < 0.0001). Expression of GST activity in various tissues was also affected by age (P < 0.01) but lacked a consistent relationship with the changes in GPX and PHGPX activity. Tissue-specific patterns of developmental expression of these enzymes may be related to the susceptibility of organs to pro-oxidant injuries. In conclusion, expression of PHGPX mRNA and activity in various tissues of pigs is developmentally increased over ages, and the pattern is somewhat different from that of GPX.


Asunto(s)
Envejecimiento/metabolismo , Regulación Enzimológica de la Expresión Génica , Glutatión Peroxidasa/genética , Glutatión Peroxidasa/metabolismo , Porcinos/metabolismo , Animales , Animales Recién Nacidos , Dinitroclorobenceno/metabolismo , Glutatión Transferasa/metabolismo , Peróxido de Hidrógeno/metabolismo , Peróxidos Lipídicos/metabolismo , Masculino , Fosfolípido Hidroperóxido Glutatión Peroxidasa , ARN Mensajero/genética , ARN Mensajero/metabolismo , Selenio/metabolismo , Porcinos/crecimiento & desarrollo
17.
Chem Biol Interact ; 99(1-3): 17-28, 1996 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-8620566

RESUMEN

The effects of murine AIDS infection on endogenous antioxidant defenses in mice fed the AIN-76A liquid diet were investigated. C57BL/6 female mice were divided into 2 groups: one group was injected interperitoneally with LP-BM5 murine retrovirus (MAIDS) stock, and the other group served as the non-infected control. Two weeks after the infection, the mice were killed and livers were excised for biochemical analysis of the antioxidant defenses. Liver reduced glutathione (GSH) levels and activities of both cytosolic superoxide dismutase (SOD) and mitochondrial SOD were significantly depressed by MAIDS infection. Activities of glutathione reductase (GR) selenium (Se)-dependent glutathione peroxidase (GPx), catalase and glutathione-S-transferase (GST) toward 1-chloro-2,4-dinitrobenzene (CDNB) were not affected by MAIDS infection. A previous study by this laboratory using the Lieber-DeCarli (L-D) all purpose liquid diet caused a decline in total SOD activity and GPx activity, but not GSH levels. The results suggest that MAIDS infection depresses liver antioxidant defenses; however, MAIDS infection of mice fed the AID-76A liquid diet depresses different liver antioxidant defense parameters when compared to those of the mice fed the L-D all purpose liquid diet.


Asunto(s)
Antioxidantes/metabolismo , Dieta , Hígado/metabolismo , Síndrome de Inmunodeficiencia Adquirida del Murino/metabolismo , Animales , Catalasa/metabolismo , Dinitroclorobenceno/metabolismo , Femenino , Radicales Libres/farmacología , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Selenio/metabolismo , Superóxido Dismutasa/metabolismo
18.
Cancer Res ; 54(17): 4573-5, 1994 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-8062243

RESUMEN

Mice are resistant to aflatoxin carcinogenicity primarily due to expression of a glutathione S-transferase (mYc) with high catalytic activity toward aflatoxin B1-8,9-epoxide (AFBO). In contrast, rats are more sensitive to aflatoxin carcinogenicity due to the constitutive expression of a glutathione S-transferase with relatively low catalytic activity toward AFBO (rYc1). To identify the contribution of different regions of the mYc protein that confer high catalytic activity toward AFBO, six chimeric mYc/rYc1 GST enzymes were generated utilizing full and partial restriction enzyme digestions at two conserved StyI sites in the mYc and rYc1 complementary DNAs (between amino acid residues 56-57 and 142-143). Recombinant wild-type and chimeric glutathione S-transferases were bacterially expressed, affinity purified, and their catalytic activities measured toward AFBO, delta 5-androstene-3,17-dione, 1-chloro-2,4-dinitrobenzene, and ethacrynic acid. The set of chimeras displayed a wide range of catalytic activities toward the substrates assayed. The chimeras with the greatest activity toward AFBO were 1:56rat-57: 221mouse and 1:56mouse-57:142rat-143:221mouse, with AFBO conjugating activities 200 and 8 times greater than wild-type rYc1, respectively. These results demonstrate that the residues that confer high AFBO conjugation activity in mYc are located in the region spanning residues 57-221.


Asunto(s)
Aflatoxina B1/metabolismo , Dinitroclorobenceno/metabolismo , Glutatión Transferasa/química , Proteínas Recombinantes de Fusión/química , Secuencia de Aminoácidos , Androstenodiona/análogos & derivados , Androstenodiona/metabolismo , Ácido Etacrínico/metabolismo , Glutatión Transferasa/genética , Glutatión Transferasa/metabolismo , Datos de Secuencia Molecular , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA